Keratoacanthoma: a tumor in search of a classification
2007; Wiley; Volume: 46; Issue: 7 Linguagem: Inglês
10.1111/j.1365-4632.2007.03260.x
ISSN1365-4632
Autores Tópico(s)Hedgehog Signaling Pathway Studies
ResumoInternational Journal of DermatologyVolume 46, Issue 7 p. 671-678 Keratoacanthoma: a tumor in search of a classification Amel Karaa MD, Amel Karaa MD From the Department of Biology, UNC Charlotte, North Carolina, and Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NYSearch for more papers by this authorAmor Khachemoune MD, CWS, Amor Khachemoune MD, CWS From the Department of Biology, UNC Charlotte, North Carolina, and Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NYSearch for more papers by this author Amel Karaa MD, Amel Karaa MD From the Department of Biology, UNC Charlotte, North Carolina, and Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NYSearch for more papers by this authorAmor Khachemoune MD, CWS, Amor Khachemoune MD, CWS From the Department of Biology, UNC Charlotte, North Carolina, and Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NYSearch for more papers by this author First published: 03 July 2007 https://doi.org/10.1111/j.1365-4632.2007.03260.xCitations: 70 Amor Khachemoune, MD, CWS Ronald O. Perelman Department of Dermatology New York University School of Medicine 530 First Avenue New York, NY 10016 E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 2004; 30: 326–333. 10.1111/j.1524-4725.2004.30080.x PubMedWeb of Science®Google Scholar 2 Hutchinson JA. Morbid growths and tumours: the crateriform ulcer of the face, a form of acute epithelial cancer. Trans Pathol Soc Lond 1889; 40: 275–281. Google Scholar 3 Musso L. Spontaneous resolution of a molluscum sebaceum. Proc R Soc Med 1950; 43: 838–839. CASPubMedWeb of Science®Google Scholar 4 Halnan KE. Molluscum pseudocarcinomatosum. Lancet 1953; 265: 1358. 10.1016/S0140-6736(53)91287-2 CASPubMedWeb of Science®Google Scholar 5 Rulon DB, Helwig EB. Cutaneous sebaceous neoplasms. Cancer 1974; 33: 82–102. 10.1002/1097-0142(197401)33:1 3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar 6 Brown JB, Fryer MP. Fallacy of term self-healing epidermoid carcinoma and limitations of microscopic interpretations. Surg Gynecol Obstet 1955; 100: 179–183. CASPubMedWeb of Science®Google Scholar 7 Rudolph R, Gray AP, Leipold HW. Intracutaneous cornifying epithelioma ("keratoacanthoma") of dogs and keratoacanthoma of man. Cornell Vet 1977; 67: 254–264. CASPubMedWeb of Science®Google Scholar 8 Grinspan D, Abulafia J. Idiopathic cutaneous pseudoepitheliomatous hyperplasia, verrugoma (Gougerot), molluscum sebaceum (MacCormac and Scarff), self-healing, primary, squamous-cell epithelioma (Ferguson Smith), and keratoacanthoma (Rook and Whimster). Cancer 1955; 8: 1047–1056. 10.1002/1097-0142(1955)8:5 3.0.CO;2-V CASPubMedWeb of Science®Google Scholar 9 Miedzinski F, Kozakiewicz J. Keratoacanthoma centrifugum – a special variety of keratoacanthoma. Hautarzt 1962; 13: 348–352. CASPubMedGoogle Scholar 10 Kwittken J. A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma). Mt Sinai J Med 1975; 42: 127–135. CASPubMedWeb of Science®Google Scholar 11 Buescher L, DeSpain JD, Diaz-Arias AA, et al. Keratoacanthoma arising in an organoid nevus during childhood: case report and literature review. Pediatr Dermatol 1991; 8: 117–119. 10.1111/j.1525-1470.1991.tb00298.x CASPubMedWeb of Science®Google Scholar 12 Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332–342. 10.1097/00000372-199308000-00007 CASPubMedWeb of Science®Google Scholar 13 Maruani A, Michenet P, Lagasse JP, et al. [Keratoacanthoma of the anal margin]. Gastroenterol Clin Biol 2004; 28: 906–908. 10.1016/S0399-8320(04)95156-1 PubMedWeb of Science®Google Scholar 14 Perdigao FB, Pierre-Filho Pde T, Natalino RJ, et al. Conjunctival keratoacanthoma. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 135–137. 10.1590/S0041-87812004000300008 PubMedGoogle Scholar 15 Miot HA, Miot LD, Da Costa AL, et al. Association between solitary keratoacanthoma and cigarette smoking: a case–control study. Dermatol Online J 2006; 12: 2. PubMedGoogle Scholar 16 Reizner GT, Chuang TY, Elpern DJ, et al. Keratoacanthoma in Japanese Hawaiians in Kauai, Hawaii. Int J Dermatol 1995; 34: 851–853. 10.1111/j.1365-4362.1995.tb04420.x CASPubMedWeb of Science®Google Scholar 17 Sullivan JJ. Keratoacanthoma: the Australian experience. Australas J Dermatol 1997; 38: S36–S39. 10.1111/j.1440-0960.1997.tb01007.x PubMedGoogle Scholar 18 Dufresne RG, Marrero GM, Robinson-Bostom L. Seasonal presentation of keratoacanthomas in Rhode Island. Br J Dermatol 1997; 136: 227–229. 10.1046/j.1365-2133.1997.d01-1174.x CASPubMedWeb of Science®Google Scholar 19 Ponti G, Ponz de Leon M. Muir–Torre syndrome. Lancet Oncol 2005; 6: 980–987. 10.1016/S1470-2045(05)70465-4 PubMedWeb of Science®Google Scholar 20 Consigli JE, Gonzalez ME, Morsino R, et al. Generalized eruptive keratoacanthoma (Grzybowski variant). Br J Dermatol 2000; 142: 800–803. 10.1046/j.1365-2133.2000.03430.x CASPubMedWeb of Science®Google Scholar 21 Chowdhury RK, Padhi T, Das GS. Keratoacanthoma of the conjunctiva complicating xeroderma pigmentosum. Indian J Dermatol Venereol Leprol 2005; 71: 430–431. 10.4103/0378-6323.18954 CASPubMedGoogle Scholar 22 Craddock KJ, Rao J, Lauzon GJ, et al. Multiple keratoacanthomas arising post-UVB therapy. J Cutan Med Surg 2004; 8: 239–243. 10.1007/s10227-004-0122-8 PubMedWeb of Science®Google Scholar 23 Talve L, Stenback F, Jansen CT. UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice. Photodermatol Photoimmunol Photomed 1990; 7: 109–115. CASPubMedWeb of Science®Google Scholar 24 Chuang TY, Heinrich LA, Schultz MD, et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26: 173–177. 10.1016/0190-9622(92)70021-7 PubMedWeb of Science®Google Scholar 25 Letzel S, Drexler H. Occupationally related tumors in tar refinery workers. J Am Acad Dermatol 1998; 39: 712–720. 10.1016/S0190-9622(98)70043-X CASPubMedWeb of Science®Google Scholar 26 Heidenreich RK, Gongloff RK, Wescott WB. A solitary, exophytic, crateriform lesion on the mandibular retromolar gingiva. J Am Dent Assoc 1986; 112: 377–379. 10.1016/S0002-8177(86)23020-2 CASPubMedWeb of Science®Google Scholar 27 Jarvholm B, Easton D. Models for skin tumour risks in workers exposed to mineral oils. Br J Cancer 1990; 62: 1039–1041. 10.1038/bjc.1990.435 CASPubMedWeb of Science®Google Scholar 28 Pattee SF, Silvis NG. Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature. J Am Acad Dermatol 2003; 48: S35–S38. 10.1067/mjd.2003.114 PubMedWeb of Science®Google Scholar 29 Epstein EH Jr, Epstein EH. Keratoacanthoma recurrent after surgical excision. J Dermatol Surg Oncol 1978; 4: 524–525. 10.1111/j.1524-4725.1978.tb00489.x PubMedGoogle Scholar 30 Poleksic S, Yeung KY. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? Cancer 1978; 41: 12–16. 10.1002/1097-0142(197801)41:1 3.0.CO;2-7 CASPubMedWeb of Science®Google Scholar 31 Goldberg LH, Silapunt S, Beyrau KK, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol 2004; 50: 753–758. 10.1016/j.jaad.2003.11.065 PubMedWeb of Science®Google Scholar 32 Batinac T, Zamolo G, Coklo M, et al. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Pathol Res Pract 2006; 202: 599–607. 10.1016/j.prp.2006.04.004 CASPubMedWeb of Science®Google Scholar 33 Hu W, Cook T, Oh CW, et al. Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma. J Am Acad Dermatol 2000; 42: 473–475. 10.1016/S0190-9622(00)90221-4 CASPubMedWeb of Science®Google Scholar 34 Clausen OP, Beigi M, Bolund L, et al. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 2002; 119: 1367–1372. 10.1046/j.1523-1747.2002.19613.x CASPubMedWeb of Science®Google Scholar 35 Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir–Torre syndrome. J Cutan Pathol 2002; 29: 415–420. 10.1034/j.1600-0560.2002.290705.x CASPubMedWeb of Science®Google Scholar 36 Langenbach N, Kroiss MM, Ruschoff J, et al. Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas. Arch Dermatol Res 1999; 291: 1–5. 10.1007/s004030050376 CASPubMedWeb of Science®Google Scholar 37 Forslund O, DeAngelis PM, Beigi M, et al. Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol 2003; 30: 423–429. 10.1034/j.1600-0560.2003.00092.x CASPubMedWeb of Science®Google Scholar 38 Saftic M, Batinac T, Zamolo G, et al. HPV 6-positive giant keratoacanthoma in an immunocompetent patient. Tumori 2006; 92: 79–82. 10.1177/030089160609200114 PubMedWeb of Science®Google Scholar 39 Stockfleth E, Meinke B, Arndt R, et al. Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients. Dermatology 1999; 198: 122–125. 10.1159/000018086 CASPubMedWeb of Science®Google Scholar 40 Hsi ED, Svoboda-Newman SM, Stern RA, et al. Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction. Am J Dermatopathol 1997; 19: 10–15. 10.1097/00000372-199702000-00003 CASPubMedWeb of Science®Google Scholar 41 Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198–2206. 10.1002/1097-0142(19931001)72:7 3.0.CO;2-Q CASPubMedWeb of Science®Google Scholar 42 Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994; 30: 1–19. 10.1016/S0190-9622(94)70001-X CASPubMedWeb of Science®Google Scholar 43 Ghadially FN, Barton BW, Kerridge DF. The etiology of keratoacanthoma. Cancer 1963; 16: 603–611. 10.1002/1097-0142(196305)16:5 3.0.CO;2-9 PubMedWeb of Science®Google Scholar 44 Attili S, Attili VR. Keratoacanthoma centrifugum marginatum arising in vitiligo: a case report. Dermatol Online J 2006; 12: 18. PubMedGoogle Scholar 45 Oh CK, Son HS, Lee JB, et al. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 2004; 51: S177–S180. 10.1016/j.jaad.2004.05.009 PubMedWeb of Science®Google Scholar 46 Beham A, Regauer S, Soyer HP, et al. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol 1998; 5: 269–280. 10.1097/00125480-199809000-00001 CASPubMedGoogle Scholar 47 Hundeiker M. Clinical variations of keratoacanthomas. Z Hautkr 1978; 53: 563–571. CASPubMedGoogle Scholar 48 Sanchez Yus E, Simon P, Requena L, et al. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Am J Dermatopathol 2000; 22: 305–310. 10.1097/00000372-200008000-00002 CASPubMedWeb of Science®Google Scholar 49 Griffiths RW. Keratoacanthoma observed. Br J Plast Surg 2004; 57: 485–501. 10.1016/j.bjps.2004.05.007 PubMedWeb of Science®Google Scholar 50 Seifert A, Nasemann T. Keratoacanthoma and its clinical variants. Review of the literature and histopathologic analysis of 90 cases. Hautarzt 1989; 40: 189–202. CASPubMedWeb of Science®Google Scholar 51 Batinac T, Zamolo G, Coklo M, et al. Possible key role of granzyme B in keratoacanthoma regression. Med Hypotheses 2006; 66: 1129–1132. 10.1016/j.mehy.2005.12.035 CASPubMedWeb of Science®Google Scholar 52 Gottfarstein-Maruani A, Michenet P, Kerdraon R, et al. Keratoacanthoma: two cases with intravascular spread. Ann Pathol 2003; 23: 438–442. PubMedWeb of Science®Google Scholar 53 Sinha A, Marsh R, Langtry J. Spontaneous regression of subungual keratoacanthoma with reossification of underlying distal lytic phalynx. Clin Exp Dermatol 2005; 30: 20–22. 10.1111/j.1365-2230.2004.01603.x CASPubMedWeb of Science®Google Scholar 54 Freedman PD, Kerpel SM, Begel H, et al. Solitary intraoral keratoacanthoma. Report of a case. Oral Surg Oral Med Oral Pathol 1979; 47: 74–76. 10.1016/0030-4220(79)90105-1 CASPubMedWeb of Science®Google Scholar 55 Janette A, Pecaro B, Lonergan M, et al. Solitary intraoral keratoacanthoma: report of a case. J Oral Maxillofac Surg 1996; 54: 1026–1030. 10.1016/S0278-2391(96)90407-3 CASPubMedWeb of Science®Google Scholar 56 Hofer SO, Jackson IT. Self-involution of giant keratoacanthoma on the tip of the nose. Plast Reconstr Surg 2004; 113: 765–766. 10.1097/01.PRS.0000104506.22211.60 PubMedWeb of Science®Google Scholar 57 Moriyama M, Watanabe T, Sakamoto N, et al. A case of giant keratoacanthoma of the auricle. Auris Nasus Larynx 2000; 27: 185–188. 10.1016/S0385-8146(99)00073-5 CASPubMedGoogle Scholar 58 Webb AJ, Ghadially FN. Massive or giant keratoacanthoma. J Pathol Bacteriol 1966; 91: 505–509. 10.1002/path.1700910226 CASPubMedWeb of Science®Google Scholar 59 Leonard AL, Hanke CW. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil. J Drugs Dermatol 2006; 5: 454–456. PubMedGoogle Scholar 60 Chen W, Koenig C. Vulvar keratoacanthoma: a report of two cases. Int J Gynecol Pathol 2004; 23: 284–286. 10.1097/01.pgp.0000130044.25477.16 PubMedWeb of Science®Google Scholar 61 Sterry W, Steigleder GK, Pullmann H, et al. Eruptive keratoacanthoma. Hautarzt 1981; 32: 119–125. CASPubMedWeb of Science®Google Scholar 62 Marshall J, Findlay GH. Multiple primary self-healing squamous epithelioma of the skin (Ferguson Smith), and its relationship to molluscum sebaceum. S Afr Med J 1953; 27: 1000–1005. CASPubMedGoogle Scholar 63 Ferguson-Smith J. Multiple primary, self-healing squamous epithelioma of the skin. Br J Dermatol 1948; 60: 315–318. 10.1111/j.1365-2133.1948.tb10932.x Web of Science®Google Scholar 64 Agarwal M, Chander R, Karmakar S, et al. Multiple familial keratoacanthoma of Witten and Zak – a report of three siblings. Dermatology 1999; 198: 396–399. 10.1159/000018157 CASPubMedWeb of Science®Google Scholar 65 Ponti G, Losi L, Di Gregorio C, et al. Identification of Muir–Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005; 103: 1018–1025. 10.1002/cncr.20873 CASPubMedWeb of Science®Google Scholar 66 Wee SA. Multiple eruptive keratoacanthomas, de novo. Dermatol Online J 2004; 10: 19. PubMedGoogle Scholar 67 Bart RS, Kopf AW. Techniques of biopsy of cutaneous neoplasms. J Dermatol Surg Oncol 1979; 5: 979–987. 10.1111/j.1524-4725.1979.tb00796.x CASPubMedGoogle Scholar 68 Cribier B, Asch P, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199: 208–212. 10.1159/000018276 CASPubMedWeb of Science®Google Scholar 69 Ackerman AB. Squamous-cell carcinoma vs. keratoacanthoma. J Dermatol Surg Oncol 1982; 8: 418. 10.1111/j.1524-4725.1982.tb01102.x CASPubMedWeb of Science®Google Scholar 70 Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol 2003; 16: 8–13. 10.1097/01.MP.0000043520.74056.CD PubMedWeb of Science®Google Scholar 71 Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001; 158: 1633–1637. 10.1016/S0002-9440(10)64119-3 CASPubMedWeb of Science®Google Scholar 72 Kerschmann RL, McCalmont TH, LeBoit PE. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 1994; 130: 181–186. PubMedWeb of Science®Google Scholar 73 Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol 1995; 17: 324–331. CASPubMedWeb of Science®Google Scholar 74 Putti TC, Teh M, Lee YS. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers. Mod Pathol 2004; 17: 468–475. 10.1038/modpathol.3800063 CASPubMedWeb of Science®Google Scholar 75 Skalova A, Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections. Am J Dermatopathol 1995; 17: 332–334. 10.1097/00000372-199508000-00004 CASPubMedWeb of Science®Google Scholar 76 Ho T, Horn T, Finzi E. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol 1991; 127: 1167–1171. CASPubMedWeb of Science®Google Scholar 77 Kannon G, Park HK. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma. Am J Dermatopathol 1990; 12: 31–36. 10.1097/00000372-199002000-00005 PubMedWeb of Science®Google Scholar 78 Ariano MC, Wiley EL, Ariano L, et al. H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin. J Dermatol Surg Oncol 1985; 11: 1076–1083. 10.1111/j.1524-4725.1985.tb01396.x CASPubMedWeb of Science®Google Scholar 79 Kaabipour E, Haupt HM, Stern JB, et al. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study. Arch Pathol Lab Med 2006; 130: 69–73. PubMedWeb of Science®Google Scholar 80 Tran TA, Ross JS, Sheehan CE, et al. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Mod Pathol 2000; 13: 427–432. 10.1038/modpathol.3880073 CASPubMedWeb of Science®Google Scholar 81 Mukunyadzi P, Sanderson RD, Fan CY, et al. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma. Mod Pathol 2002; 15: 45–49. 10.1038/modpathol.3880488 PubMedWeb of Science®Google Scholar 82 Biesterfeld S, Josef J. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry. Anticancer Res 2002; 22: 3019–3023. CASPubMedWeb of Science®Google Scholar 83 Kuivanen TT, Jeskanen L, Kyllonen L, et al. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol 2006; 19: 1203–1212. 10.1038/modpathol.3800633 CASPubMedWeb of Science®Google Scholar 84 Asch PH, Basset P, Roos M, et al. Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma. Am J Dermatopathol 1999; 21: 146–150. 10.1097/00000372-199904000-00006 CASPubMedWeb of Science®Google Scholar 85 Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology 2005; 47: 170–178. 10.1111/j.1365-2559.2005.02155.x CASPubMedWeb of Science®Google Scholar 86 Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas?: a comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 2006; 126: 2308–2315. 10.1038/sj.jid.5700375 CASPubMedWeb of Science®Google Scholar 87 Wiemers S, Stengel R, Schopf E, et al. Subungual keratoacanthoma. Hautarzt 1994; 45: 25–28. 10.1007/PL00013250 CASPubMedWeb of Science®Google Scholar 88 Shriner DL, McCoy DK, Goldberg DJ, et al. Mohs micrographic surgery. J Am Acad Dermatol 1998; 39: 79–97. 10.1016/S0190-9622(98)70405-0 CASPubMedWeb of Science®Google Scholar 89 Griffiths RW, Feeley K, Suvarna SK. Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in a minimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg 2002; 55: 287–292. 10.1054/bjps.2002.3833 CASPubMedWeb of Science®Google Scholar 90 Ansai S, Manabe M. Possible spontaneous regression of a metastatic lesion of keratoacanthoma-like squamous cell carcinoma in a regional lymph node. J Dermatol 2005; 32: 899–903. 10.1111/j.1346-8138.2005.tb00868.x CASPubMedWeb of Science®Google Scholar 91 Nedwich JA. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma. Australas J Dermatol 1991; 32: 137–141. 10.1111/j.1440-0960.1991.tb01777.x CASPubMedGoogle Scholar 92 Caccialanza M, Sopelana N. Radiation therapy of keratoacanthomas: results in 55 patients. Int J Radiat Oncol Biol Phys 1989; 16: 475–477. 10.1016/0360-3016(89)90345-3 CASPubMedWeb of Science®Google Scholar 93 Neumann RA, Knobler RM. Argon laser treatment of small keratoacanthomas in difficult locations. Int J Dermatol 1990; 29: 733–736. 10.1111/j.1365-4362.1990.tb03783.x CASPubMedWeb of Science®Google Scholar 94 Thiele JJ, Ziemer M, Fuchs S, et al. Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. Dermatol Surg 2004; 30: 1556–1560. 10.1111/j.1524-4725.2004.30559.x PubMedWeb of Science®Google Scholar 95 Georgieva VB, Ziangirova GG, Kasparov AA. Results of a multi-year use of combined laser-surgical treatment in tumors of the epibulbar and limbocorneal localizations. Vestn Oftalmol 2004; 120: 3–5. CASPubMedGoogle Scholar 96 Gray RJ, Meland NB. Topical 5-fluorouracil as primary therapy for keratoacanthoma. Ann Plast Surg 2000; 44: 82–85. 10.1097/00000637-200044010-00015 CASPubMedWeb of Science®Google Scholar 97 Sanders S, Busam KJ, Halpern AC, et al. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy. Dermatol Surg 2002; 28: 954–958. 10.1046/j.1524-4725.2002.02069.x CASPubMedWeb of Science®Google Scholar 98 Sayama S, Tagami H. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol 1983; 109: 449–452. 10.1111/j.1365-2133.1983.tb04619.x CASPubMedWeb of Science®Google Scholar 99 Andreassi A, Pianigiani E, Taddeucci P, et al. Guess what! Keratoacanthoma treated with intralesional bleomycin. Eur J Dermatol 1999; 9: 403–405. CASPubMedWeb of Science®Google Scholar 100 Di Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 2004; 18: 626–629. 10.1111/j.1468-3083.2004.01025.x CASPubMedWeb of Science®Google Scholar 101 Cohen PR, Schulze KE, Teller CF, et al. Intralesional methotrexate for keratoacanthoma of the nose. Skinmed 2005; 4: 393–395. 10.1111/j.1540-9740.2005.04331.x PubMedGoogle Scholar 102 Cham BE, Daunter B, Evans RA. Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Lett 1991; 59: 183–192. 10.1016/0304-3835(91)90140-D CASPubMedWeb of Science®Google Scholar 103 McNairy DJ. Intradermal triamcinolone therapy of keratoacanthomas. Arch Dermatol 1964; 89: 136–140. 10.1001/archderm.1964.01590250142024 CASPubMedWeb of Science®Google Scholar 104 Levine N, Miller RC, Meyskens FL Jr. Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas. Arch Dermatol 1984; 120: 1215–1217. 10.1001/archderm.120.9.1215 CASPubMedGoogle Scholar 105 Tarnowski WM. Multiple keratoacanthomata. Response of a case to systemic chemotherapy. Arch Dermatol 1966; 94: 74–80. CASPubMedWeb of Science®Google Scholar 106 Oakley A, Ng S. Grzybowski's generalized eruptive keratoacanthoma: remission with cyclophosphamide. Australas J Dermatol 2005; 46: 118–123. 10.1111/j.1440-0960.2005.00157.x CASPubMedGoogle Scholar 107 Grau MV, Baron JA, Langholz B, et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 2006; 119: 682–686. 10.1002/ijc.21878 CASPubMedWeb of Science®Google Scholar 108 Butler GJ, Neale R, Green AC, et al. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005; 53: 966–972. 10.1016/j.jaad.2005.05.049 PubMedWeb of Science®Google Scholar Citing Literature Volume46, Issue7July 2007Pages 671-678 ReferencesRelatedInformation
Referência(s)